F

Fate Therapeutics
D

FATE

1.27000
USD
0.02
(1.60%)
مغلق
حجم التداول
45,386
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
144,645,803
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    B
    BLUE
    0.05000
    (0.60%)
    8.35000 USD
    C
    CLLS
    -0.03000
    (-1.98%)
    1.48500 USD
    C
    CRSP
    0.260
    (0.65%)
    40.520 USD
    E
    EDIT
    -0.03000
    (-2.40%)
    1.22000 USD
    N
    NTLA
    0.09000
    (0.96%)
    9.50000 USD
    S
    SGMO
    -0.00500
    (-0.45%)
    1.10000 USD
    V
    VYGR
    0.01000
    (0.20%)
    5.06000 USD
    المزيد
الأخبار
المقالات

العنوان: Fate Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.